U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980623) titled 'Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction' on May 12.
Brief Summary: This cohort study aims to assess the comparative effectiveness of tirzepatide versus semaglutide with respect to cardiovascular events in patients with type 2 diabetes and heart failure with preserved ejection fraction.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes
Heart Failure
Intervention:
DRUG: Tirzepatide
Exposure group
DRUG: Semaglutide
Referent group
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Brigham and Wom...